# Metabolic Safety of Raltegravir Versus Darunavir in HIV Naive Patients

> **NCT01066065** · — · UNKNOWN · sponsor: **Hospital Carlos III, Madrid** · enrollment: 120 (estimated)

## Conditions studied

- Cardiovascular Disease
- HIV Infections

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01066065
- **Lead sponsor:** Hospital Carlos III, Madrid
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-02
- **Primary completion:** 2011-01
- **Final completion:** 2011-01
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2010-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01066065

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01066065, "Metabolic Safety of Raltegravir Versus Darunavir in HIV Naive Patients". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01066065. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*